Precision radiation aims to stall prostate cancer spread

NCT ID NCT04983095

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding precise, high-dose radiation (SBRT) to standard hormone therapy can delay cancer progression in men with prostate cancer that has spread to 1-3 spots. About 118 participants will be randomly assigned to get SBRT plus standard care or standard care alone. The goal is to see if the radiation helps keep the cancer from growing longer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stereotactic body radiotherapy (SBRT) plus standard hormone therapy
What this could lead to
If it works, this could improve control of prostate cancer that has spread to a few spots, delaying the need for stronger treatments.
What could go wrong
This is a phase III trial but still early in recruitment. The benefit may be small, and radiation can cause side effects like fatigue or local irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HORMONE SENSITIVE PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Capio St Göran Hospital

    RECRUITING

    Stockholm, Region Stockholm, Sweden

  • Karolinska University Hospital

    RECRUITING

    Stockholm, Stockholm County, Sweden

  • Region Skåne

    RECRUITING

    Lund, Lund, Sweden

  • Region Örebro Län

    RECRUITING

    Örebro, Örebro County, Sweden

  • Ryhovs county hospital

    RECRUITING

    Jönköping, Sweden

  • Södersjukhuset

    RECRUITING

    Stockholm, Region Stockholm, Sweden

  • Umeå University hospital

    RECRUITING

    Umeå, Umea, 90331, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.